Eurofins Scientific Shares Bounce 2.5% and Cross Back Over Moving Averages
The Luxembourg-based bioanalytical testing specialist significantly advances in late Paris trading, erasing the previous day's decline. The stock is among the top gainers on the CAC 40, in an index buoyed by a strong general rebound.
A Rebound That Places the Stock Above Its Three Moving Averages
Eurofins Scientific shares gain 2.33% to €68.62, offsetting a decline of nearly 3% suffered the previous day. The stock ranks among the top gainers on the CAC 40, which is up 0.65% at 8,306 points. This rebound brings the stock above its three moving averages, with a gap of 3.67% over the MM20 (€66.19) and 8.52% over the MM50 (€63.23).
The RSI at 56 remains neutral, while the price approaches the resistance identified at €69.20, which caps the session's gains. Over one month, the stock has risen by 5.76%, a dynamic consistent with the renewed interest observed since the end of June in the stock.
A Session Driven by the CAC 40's Easing After Several Tense Sessions
The movement is part of a CAC 40 that rebounds sharply after a period marked by geopolitical tensions in the Middle East. The VIX eases to 16.71, down 1.12%, signaling a reduction in caution on the equity markets. On Wall Street, the S&P 500 and Nasdaq are slightly up in session.
The Fed's minutes published yesterday, describing a divided committee but still vigilant on inflation, did not prevent the return of buyers to European stocks. Over twelve months, Eurofins Scientific has posted a gain of 14.98%, a performance that contrasts with the fluctuations experienced in the spring, notably after the April quarterly publication. The next key event to watch will be the release of the semi-annual accounts for 2026.
